With a distinguished legacy of excellence and innovation, Dr. Khaled Almosa Consulting firm stands as a leader in providing comprehensive consulting services across a myriad of industries. Under the esteemed leadership of Dr. Khaled Almosa, a visionary and pioneer in biotechnology, healthcare, business development, and investment, our firm is dedicated to delivering unparalleled expertise and strategic insights that drive success and foster growth for our clients.
At Dr. Khaled Almosa Consulting firm, we are committed to maintaining the highest standards of excellence while spearheading transformative change across various sectors. Our holistic approach, combined with our deep industry knowledge and innovative solutions, ensures that our clients achieve their strategic objectives and flourish in a rapidly evolving business landscape.
Through our extensive experience and commitment to innovation, we provide our clients with the tools and guidance necessary to navigate complex challenges and seize emerging opportunities. Our dedication to excellence is reflected in every aspect of our work, as we strive to create lasting value and drive meaningful impact for our clients and their industries.
Founding Vision and Leadership Excellence
Dr. Khaled Almosa is widely recognized as the Godfather of Biotechnology Manufacturing in Saudi Arabia —a prestigious title bestowed upon him by HE. Dr. Hussein A. Gezairy , Ex-Regional Director of the WHO Eastern Mediterranean Region, Ex-Saudi Minister of Health, and Founder of the College of Medicine at King Saud University, Riyadh, Saudi Arabia.
With a visionary outlook and over three decades of diverse experience across various industries, Dr. Almosa has played a pivotal role in shaping the biotechnology landscape in Saudi Arabia. As a true pioneer, he became the first Saudi national to invest in and establish multiple groundbreaking biotechnology manufacturing companies. His transformative initiatives have laid the foundation for a thriving biotech sector, fostering innovation, accelerating progress, and cementing Saudi Arabia’s position as a leader in biotechnology manufacturing.
Dr. Almosa’s contributions have not only revolutionized the industry but have also propelled the region to the forefront of global biotech advancement. His legacy as the Godfather of Biotechnology continues to inspire the next generation of innovators and entrepreneurs.
Beyond biotechnology, Dr. Almosa’s leadership has driven the establishment of numerous companies across diverse sectors. His strategic acumen and forward-thinking approach have positioned him as a key shareholder in multiple enterprises, actively contributing to their expansion and success. His ability to anticipate industry trends and capitalize on emerging opportunities has solidified his reputation as an influential and highly respected figure within the business community.
KSA Supreme Committee for Research, Development and Innovation, CEDA
In March 2021, Dr. Khaled Almosa received a prestigious appointment by His Royal Highness Crown Prince and Prime Minister Mohammed bin Salman to become a member of the Supreme Committee for Research, Development, and Innovation. This esteemed committee operates within the Council of Economic and Development Affairs under the Council of Ministers in Saudi Arabia. Dr. Almosa was chosen to represent the private sector, highlighting his significant contributions and expertise in fostering development and innovation in various industries.
Dr. Khaled Almosa has served as an active and influential member of the Supreme Committee for Research, Development, and Innovation during the period from 2021 to 2024. Chaired by HRH Crown Prince Mohammed bin Salman, the committee plays a critical role in shaping Saudi Arabia’s strategic vision for research, technological advancement, and economic growth.
Dr. Almosa's unparalleled expertise, particularly in the fields of biotechnology and healthcare, has been instrumental in paving the way for groundbreaking advancements in the region. His forward-thinking strategies and insightful leadership have greatly influenced the development of key initiatives and policies, strengthening Saudi Arabia’s position as a leader in innovation.
Through his work, Dr. Almosa has played a vital role in promoting a culture of research and excellence, driving transformative progress that empowers industries and communities alike. His unwavering dedication continues to leave a lasting impact on the fields of biotechnology, healthcare, and beyond, inspiring future innovations and setting new standards of achievement.
Read More
SAUDIBIO
SAUDIBIO, the first and only manufacturer of insulin and biologics in the Kingdom of Saudi Arabia, was founded by Dr. Khaled Almosa. This remarkable achievement was realized through strategic partnerships with renowned companies such as Novo Nordisk for insulin and Sandoz for biologics. In 2023, SAUDIBIO was acquired by Lifera, a company wholly owned by the Saudi Public Investment Fund (PIF).
Vaccine Industrial Holding Company (VIC)
Dr. Khaled Almosa is the founder and Chairman of the Vaccine Industrial Holding Company (VIC). VIC hosts the first human vaccine manufacturing facility in Saudi Arabia, which is also the largest in the Middle East. This state-of-the-art facility represents a significant milestone in the nation's advancements in biotechnology and public health. VIC has formed partnerships with world-class global manufacturers to ensure the highest standards in vaccine production, leveraging cutting-edge technologies and best practices to deliver high-quality vaccines to the region.
Building the Biotech Industry: Industrial Engineering and Project Management Company
Dr. Almosa was the founder and Chairman of the globally recognized industrial engineering company BIOERA, with partnerships with recognized global and local organizations such as KeyPlants, Zyme Biotech, Shahin Engineering Consultancy, Inotek, and Jadwa Contractors. Bioera serves markets across the GCC, USA, Europe, and India, further solidifying Dr. Almosa's reputation as a renowned figure in the industry. His ability to establish and lead successful biotech ventures has made a lasting impact on the global biotechnology landscape, driving innovation and setting new benchmarks for excellence in the field.
Biotech Innovation Company for R&D
Dr. Almosa also founded the Biotech Innovation Company for R&D in collaboration with the globally renowned Baylor College of Medicine. These research and development activities are now being conducted in partnership with King Abdulaziz City for Science and Technology (KACST) in Saudi Arabia. The company was granted funding from Saudi NIH to conduct clinical trials for MERS in Saudi Arabia.
Biotechnology Training Institute
Dr. Almosa is currently establishing a biotechnology training institute in collaboration with global biotech training partners, namely: NATIONAL INSTITUTE FOR BIOPROCESSING RESEARCH & TRAINING (NIBRT). This groundbreaking project aims to provide specialized training in the biotech industry for Saudi Arabia and other Middle Eastern countries. It is the first and only institute of its kind in the region, poised to play a vital role in developing a skilled workforce for the biotechnology sector.
MedTech Group of Companies
Dr. Almosa founded and chaired the MedTech Group of Companies based in Riyadh, Saudi Arabia. This group consists of a day surgery complex, medical centers, and medical supplies facilities, and is considered one of the top medical services providers in the region. The MedTech Group is known for its commitment to quality healthcare and innovative medical solutions, catering to the diverse needs of the community.
Management and Business Development Consultant
Dr. Almosa is a certified management consultant and chairman of Dr. Khaled Almosa Consulting Firm based in Riyadh, Saudi Arabia. The firm is fully licensed by the Ministry of Commerce and provides a variety of services within biotech, R&D, investment opportunities, and business development sectors.
Academic Credentials
Dr. Almosa is a certified senior consultant with extensive expertise in healthcare management and business development.
He has earned an impressive range of academic qualifications, including a bachelor's degree in Medical Sciences from King Saud University (KSU) in Saudi Arabia, a master’s degree in Healthcare Management from Birmingham University in the United Kingdom, a PhD in Professional Studies from Hull University in the United Kingdom, and a Doctor of Business Administration (DBA) from SWISS Business School in Switzerland. Additionally, he holds a certification in Leadership Principles from Harvard Business School in the United States.
These remarkable credentials underscore Dr. Almosa's unwavering commitment to excellence and his profound knowledge across his areas of expertise.
Academic and Professional Credentials
Dr. Almosa is a certified senior consultant with extensive expertise in healthcare management and business development.
He has earned an impressive range of academic qualifications, including a bachelor's degree in Medical Sciences from King Saud University (KSU) in Saudi Arabia, a master’s degree in Healthcare Management from Birmingham University in the United Kingdom, a PhD in Professional Studies from Hull University in the United Kingdom, and a Doctor of Business Administration (DBA) from SWISS Business School in Switzerland. Additionally, he holds a certification in Leadership Principles from Harvard Business School in the United States.
These remarkable credentials underscore Dr. Almosa's unwavering commitment to excellence and his profound knowledge across his areas of expertise.
Researches
Dr. Almosa has led groundbreaking research, including the study titled "Investigating Factors That Impede Successful Vaccine Manufacturing Business in the Kingdom of Saudi Arabia: Imperatives for Healthcare Sustainability." This research aims to identify and address the challenges hindering successful vaccine manufacturing in the Kingdom, proposing strategies to enhance healthcare sustainability and support the Kingdom's Vision 2030 goals.
Author
Dr. Almosa is the author of the book My Mission to Save Lives in Saudi Arabia: Localizing Insulin, Vaccines, and Cancer Therapies Through Biotechnology Manufacturing. In this book, he shares his inspiring journey and the challenges he overcame to establish a thriving biotechnology industry in Saudi Arabia. His story serves as a testament to the power of perseverance, innovation, and visionary leadership in achieving remarkable accomplishments.
Management Consulting
Our expert consultants deliver customized solutions to improve performance, streamline operations, and drive sustainable growth, offering strategic guidance and insights to help businesses overcome challenges and seize opportunities.
Healthcare Services Consulting
With extensive healthcare management experience, we provide expert consulting to healthcare providers, hospitals, and medical institutions, focusing on optimizing delivery, improving patient outcomes, and ensuring operational efficiency through innovative strategies.
Biotechnology Manufacturing Consulting
As biotech pioneers, we offer specialized consulting in biotech manufacturing, covering facility design, regulatory compliance, process optimization, and quality control to help clients excel and stay ahead of industry trends.
Research, Development and Innovation
Innovation drives our consulting services as we collaborate with research institutions to advance scientific knowledge, develop new technologies, and tackle global challenges.
Business Development
We help companies expand market reach, identify opportunities, and achieve growth through strategic planning, market analysis, and partnership development.
Training and Education
We offer comprehensive training programs, including courses, workshops, and certifications in healthcare, biotechnology, and business management, to equip professionals with the skills needed to excel.
Investment Consultancy and Real Estate Development
We offer strategic investment advice across sectors, including real estate, helping clients make informed decisions, maximize returns, and achieve financial goals through market analysis and risk assessment.